ArticleBreast care (Basel, Switzerland)2021

The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio as a Predictor of the 5-Year Survival in Stage 1-3 Triple Negative Breast Cancer Patients.

Basem Azab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.